TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05057611 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study NCT05451550 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000712 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05716516 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06068829 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT06356844 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05330221 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05195047 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05514327 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT04833322 — Predictive Biomarker (PRD): SLC35A2 mRNA
Genes: SLC35A2; UGALT; UGT; UGTL
Study NCT04068376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06666959 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06666959 — Safety Biomarker (SAF): Interleukin 1
Study NCT06666959 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06666959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06666959 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06666959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04927546 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04927546 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04532372 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04431960 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06667180 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06667180 — Safety Biomarker (SAF): BDNF
Study NCT06650371 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06175468 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05749900 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06667544 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00533741 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00533741 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06668753 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06450873 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06450873 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06621940 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study NCT06621940 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06667882 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT05640271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06348940 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06485752 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06501534 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05697237 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT05697237 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT06447662 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06650332 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06370871 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06370871 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT06370871 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06307756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05520034 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06465160 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04846010 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06140108 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05918939 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05215509 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05215509 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05665556 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04977375 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06345313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06345313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06244433 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study NCT06586060 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06159556 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05111600 — Predictive Biomarker (PRD): LAMB3 mRNA
Genes: LAMB3; LAMNB1
Study NCT04834687 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06615076 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05742269 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04338555 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04338555 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT06537921 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06537921 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT06227884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05807802 — Predictive Biomarker (PRD): FSTL1 mRNA
Genes: FSTL1; FRP
Study NCT06735391 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06735391 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06491394 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT06491394 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT04624373 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04624373 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04624373 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04624373 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05214196 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05391607 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT06470594 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06470594 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT05622058 — Predictive Biomarker (PRD): MDM4 mRNA
Genes: MDM4; MDMX
Study NCT05622058 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT05622058 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06555952 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06503367 — Predictive Biomarker (PRD): LAMA2 mRNA
Genes: LAMA2; LAMM
Study NCT02414178 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04910685 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04369131 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04739202 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04739202 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04739202 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04739202 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04739202 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05426850 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06246968 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06246786 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT05001282 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT06658509 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06456749 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04821895 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04821895 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT04740034 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05889728 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06441721 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06068660 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05363267 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00001023 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06733610 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06733610 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05070819 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT05788510 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06098300 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06506461 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05410743 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT06149793 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06549101 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06281210 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06261086 — Predictive Biomarker (PRD): GSDMD mRNA
Genes: GSDMD; DFNA5L; GSDMDC1; FKSG10
Study NCT05245409 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT05196581 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05682170 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT06470802 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05651373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05888506 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06335992 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT04733326 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06371040 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06371040 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05979389 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04450654 — Predictive Biomarker (PRD): HMGCR mRNA
Genes: HMGCR
Study NCT06178653 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06245811 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05901376 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-20a
Genes: MIR20A
Study NCT05901376 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study NCT05901376 — Predictive Biomarker (PRD): miR-106b
Genes: MIR106B
Study NCT05901376 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-223
Genes: MIR223
Study NCT05756153 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04429776 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05493683 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06090903 — Predictive Biomarker (PRD): DCN mRNA
Genes: DCN; SLRR1B
Study NCT06093789 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05427721 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT05427721 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study NCT05562791 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03733067 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06196541 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04866654 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05742360 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04721821 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05236270 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06576505 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06175338 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05228574 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04975256 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06174298 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT06236906 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04887922 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04780932 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04780932 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT04780932 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06735664 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06735664 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06736561 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05301673 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04142177 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT04752475 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06493981 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05432349 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT04977050 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06310291 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT05191758 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06213948 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT04635683 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT06668285 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05621616 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT06260189 — Predictive Biomarker (PRD): CIRBP mRNA
Genes: CIRBP; A18HNRNP; CIRP
Study NCT06100718 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06063317 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05694520 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05623124 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT00000820 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000820 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00000820 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05553704 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06665919 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05326425 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05326425 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06618716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05192798 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06348927 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06682312 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05219500 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05712460 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05514821 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05666765 — Predictive Biomarker (PRD): SAA1 mRNA
Genes: SAA1
Study NCT05957939 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05957939 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06526117 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05093725 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT05093725 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05093725 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT05093725 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05093725 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05033652 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06194825 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT05650749 — Predictive Biomarker (PRD): GPC2 mRNA
Genes: GPC2
Study NCT04961944 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06265077 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06477055 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05898464 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05728359 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06652243 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT06279871 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06279871 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05319028 — Predictive Biomarker (PRD): CD79B mRNA
Genes: CD79B; B29; IGB
Study NCT06736184 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06586125 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05006352 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05570214 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05299359 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06588335 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT06589388 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05163158 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05472090 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06705127 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06705127 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06706713 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06706713 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06705166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04492488 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03963453 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06439134 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06499025 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT06499025 — Predictive Biomarker (PRD): RUNX1T1 mRNA
Genes: RUNX1T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2
Study NCT05192889 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04688242 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT05024630 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04871165 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05802992 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT04626583 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05512247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05581979 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04869475 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06048315 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06048315 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06048315 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT06048315 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06048315 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06048315 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT06296745 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06296745 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04802031 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06249438 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04998396 — Predictive Biomarker (PRD): ASPA mRNA
Genes: ASPA; ACY2; ASP
Study NCT04970043 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05574686 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05169125 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04762381 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06426316 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT04784767 — Surrogate Endpoint (SUR): Neutralizing antibody